Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4462024
Max Phase: Preclinical
Molecular Formula: C20H20N2O
Molecular Weight: 304.39
Molecule Type: Unknown
Associated Items:
ID: ALA4462024
Max Phase: Preclinical
Molecular Formula: C20H20N2O
Molecular Weight: 304.39
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1/C(=C/c2ccccc2)C(N2CCNCC2)c2ccccc21
Standard InChI: InChI=1S/C20H20N2O/c23-20-17-9-5-4-8-16(17)19(22-12-10-21-11-13-22)18(20)14-15-6-2-1-3-7-15/h1-9,14,19,21H,10-13H2/b18-14+
Standard InChI Key: LGBSKFHLZIMOKO-NBVRZTHBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 304.39 | Molecular Weight (Monoisotopic): 304.1576 | AlogP: 2.91 | #Rotatable Bonds: 2 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.11 | CX LogP: 2.99 | CX LogD: 1.28 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.87 | Np Likeness Score: -0.11 |
1. (2015) Small molecule inhibitors of Dusp6 and uses therefor, |
Source(1):